HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helmut Drexler Selected Research

Acute Coronary Syndrome

9/2010Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.
11/2009Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.
6/2009Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
10/2007Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
2/2007Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
3/2005Angiotensin II induces MMP-2 in a p47phox-dependent manner.
11/2004Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
10/2003From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
10/2003From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helmut Drexler Research Topics

Disease

37Heart Failure
08/2011 - 01/2002
24Myocardial Infarction
03/2012 - 06/2002
13Hypertrophy
02/2011 - 01/2002
12Coronary Artery Disease (Coronary Atherosclerosis)
10/2010 - 02/2003
11Atherosclerosis
10/2010 - 09/2002
11Infarction (Infarctions)
07/2010 - 11/2003
9Fibrosis (Cirrhosis)
02/2011 - 07/2004
9Inflammation (Inflammations)
10/2010 - 03/2002
9Acute Coronary Syndrome
09/2010 - 10/2003
9Cardiovascular Diseases (Cardiovascular Disease)
04/2010 - 03/2002
7Hypertension (High Blood Pressure)
06/2010 - 04/2002
6Ischemia
01/2009 - 08/2004
5Thrombosis (Thrombus)
03/2012 - 02/2006
5Cardiomyopathies (Cardiomyopathy)
08/2011 - 05/2004
5Cardiomegaly (Heart Hypertrophy)
08/2010 - 03/2003
5ST Elevation Myocardial Infarction
12/2009 - 07/2004
4Atherosclerotic Plaque (Atheroma)
10/2010 - 11/2004
4Vascular Remodeling
11/2009 - 03/2002
4Atrial Fibrillation
06/2008 - 07/2003
3Coronary Disease (Coronary Heart Disease)
04/2010 - 03/2003
3Neointima
11/2009 - 10/2004
3Reperfusion Injury
11/2008 - 02/2006
3Ventricular Remodeling
03/2007 - 10/2004
2Stroke (Strokes)
04/2012 - 07/2007
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2011 - 01/2010
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2011 - 07/2006
2Thromboembolism
02/2011 - 04/2008
2Left Ventricular Dysfunction
02/2011 - 10/2004
2Heart Diseases (Heart Disease)
04/2010 - 11/2009
2Type 2 Diabetes Mellitus (MODY)
01/2010 - 07/2007
2Iron Deficiencies
12/2009 - 11/2009
2Anemia
12/2009 - 09/2007
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2009 - 09/2008
2Acute-Phase Reaction
11/2009 - 08/2007
2Ventricular Tachycardia
03/2008 - 08/2006
2Ventricular Fibrillation
03/2008 - 08/2006
2Cardiac Arrhythmias (Arrythmia)
12/2007 - 06/2002
2Diabetes Mellitus
10/2007 - 07/2007
2Pathologic Constriction (Stenosis)
03/2006 - 02/2006
2Neoplasms (Cancer)
09/2005 - 07/2005

Drug/Important Bio-Agent (IBA)

9Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011 - 03/2002
8Interleukin-6 (Interleukin 6)IBA
09/2010 - 11/2003
8CytokinesIBA
07/2010 - 01/2002
8Angiotensin IIIBA
09/2008 - 01/2002
7Growth Differentiation Factor 15IBA
10/2010 - 02/2006
7Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2010 - 01/2002
7Reactive Oxygen Species (Oxygen Radicals)IBA
07/2007 - 12/2002
6NADPH Oxidases (NAD(P)H oxidase)IBA
02/2011 - 02/2003
6Biomarkers (Surrogate Marker)IBA
10/2010 - 02/2007
6Proteins (Proteins, Gene)FDA Link
08/2010 - 03/2005
5Superoxides (Superoxide)IBA
06/2011 - 02/2003
5Nitric Oxide Synthase (NO Synthase)IBA
02/2011 - 10/2002
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2009 - 03/2002
5Xanthine OxidaseIBA
07/2007 - 12/2002
4CalcineurinIBA
08/2010 - 08/2002
4Losartan (Cozaar)FDA LinkGeneric
11/2009 - 04/2002
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2008 - 06/2003
3oxidized low density lipoproteinIBA
10/2010 - 09/2007
3Brain Natriuretic Peptide (Natrecor)FDA Link
09/2010 - 08/2002
3IrbesartanFDA LinkGeneric
09/2010 - 08/2008
3Angiotensin Receptor AntagonistsIBA
11/2009 - 10/2006
3InterleukinsIBA
11/2009 - 11/2003
3Transforming Growth Factor beta (TGF-beta)IBA
06/2009 - 02/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2009 - 02/2002
3LDL Lipoproteins (beta Lipoproteins)IBA
08/2008 - 07/2004
3N 30IBA
08/2008 - 07/2004
3pro-brain natriuretic peptide (1-76)IBA
03/2008 - 08/2006
3Allopurinol (Remid)FDA LinkGeneric
04/2007 - 07/2002
3C-Reactive ProteinIBA
02/2007 - 06/2004
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2007 - 06/2003
3Transcription Factors (Transcription Factor)IBA
07/2006 - 08/2002
3Superoxide DismutaseIBA
02/2003 - 09/2002
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2011 - 11/2008
2Eplerenone (Inspra)FDA LinkGeneric
06/2010 - 09/2004
2Bromocriptine (Parlodel)FDA LinkGeneric
03/2010 - 12/2007
2DiureticsIBA
03/2010 - 12/2007
2CreatinineIBA
03/2010 - 02/2007
2ferric carboxymaltoseIBA
12/2009 - 11/2009
2Hemoglobins (Hemoglobin)IBA
12/2009 - 09/2007
2IronIBA
12/2009 - 11/2009
2ProlactinIBA
12/2007 - 02/2007
2TroponinIBA
10/2007 - 02/2007
2Uric Acid (Urate)IBA
09/2007 - 09/2002
2Pharmaceutical PreparationsIBA
08/2007 - 10/2004
2Oxidants (Oxidizing Agents)IBA
07/2007 - 03/2007
2Oxidoreductases (Dehydrogenase)IBA
07/2007 - 06/2003
2NADP (NADPH)IBA
07/2007 - 02/2003
2EnzymesIBA
03/2007 - 02/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 09/2005
2p38 Mitogen-Activated Protein KinasesIBA
10/2006 - 04/2005
2CatecholaminesIBA
07/2006 - 01/2002
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2006 - 09/2005
2LipidsIBA
09/2005 - 11/2004

Therapy/Procedure

26Therapeutics
04/2012 - 10/2003
7Stents
03/2012 - 10/2004
7Cell- and Tissue-Based Therapy (Cell Therapy)
04/2010 - 12/2004
5Percutaneous Coronary Intervention
12/2009 - 07/2004
3Ligation
02/2011 - 06/2002
3Transplantation
04/2010 - 08/2005
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2008 - 08/2006